Elanco Animal Health (ELAN) Gross Margin (2017 - 2026)

Elanco Animal Health has disclosed Gross Margin across 10 years of filings, most recently posting 57.26% for Q1 2026.

• Gross Margin for Q1 2026 came in at 57.26%, down 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.06% (up 17.0% YoY), and the FY2025 annual result was 54.99%, up 12.0% from the prior year.
• Gross Margin came in at 57.26% for Q1 2026 at Elanco Animal Health, up from 51.49% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 60.7% in Q1 2023 to a low of 50.14% in Q4 2023.
• The 5-year median for Gross Margin is 57.26% (2026), against an average of 55.62%.
• Across the five-year window, Gross Margin jumped 402 bps in 2022 and plunged 437 bps in 2023, its largest moves.
• Elanco Animal Health's Gross Margin stood at 54.52% in 2022, then retreated by 8 bps to 50.14% in 2023, then gained by 1 bps to 50.88% in 2024, then rose by 1 bps to 51.49% in 2025, then increased by 11 bps to 57.26% in 2026.
• The last three Gross Margin figures came in at 57.26% (Q1 2026), 51.49% (Q4 2025), and 53.39% (Q3 2025), per Business Quant data.